OKYO PharmaSTU:OK10 23 Market Cap is €87.61 Mil as of Jul. 04, 2026. GuruFocus rates STU:OK10 with a GF Score™ of 23/100. The stock has 3 warning signs investors should review. Among 1,426 Biotechnology companies, OKYO Pharma ranks worse than 55.96% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). OKYO Pharma's share price for the quarter that ended in Sep. 2025 was €2.16. OKYO Pharma's Shares Outstanding (EOP) for the quarter that ended in Sep. 2025 was 38.46 Mil. Therefore, OKYO Pharma's market cap for the quarter that ended in Sep. 2025 was €83.06 Mil.
OKYO Pharma's quarterly market cap
increased
from Sep. 2024 (€29.19 Mil) to Mar. 2025 (€42.86 Mil) and
increased
from Mar. 2025 (€42.86 Mil) to Sep. 2025 (€83.06 Mil).
OKYO Pharma's annual market cap
declined
from Mar. 2023 (€72.48 Mil) to Mar. 2024 (€41.67 Mil) but then
increased
from Mar. 2024 (€41.67 Mil) to Mar. 2025 (€42.86 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. OKYO Pharma's Enterprise Value for Today is €84.08 Mil.
OKYO Pharma (STU:OK10) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
OKYO Pharma Market Cap Related Terms
OKYO Pharma Market Cap Historical Data
* Premium members only.
The historical data trend for OKYO Pharma's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:OK10 vs ENTX, HRTX, RANI: Market Cap Comparison
For the Biotechnology subindustry, OKYO Pharma's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
OKYO Pharma Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, OKYO Pharma's Market Cap distribution charts can be found below:
* The bar in red indicates where OKYO Pharma's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
OKYO Pharma's Market Cap for the fiscal year that ended in Mar. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OKYO Pharma (STU:OK10) has a Market Cap of €87.61 Mil as of Jul. 04, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on OKYO Pharma and its competitors. According to the industry distribution chart, OKYO Pharma ranks #798 out of 1426 companies in the Biotechnology industry, placing it in the top 56%.
Is OKYO Pharma's Market Cap too high?
OKYO Pharma's current Market Cap is €87.61 Mil. Based on the distribution chart, OKYO Pharma ranks #798 out of 1426 companies in the Biotechnology industry, which is below the industry midpoint. Overall, OKYO Pharma has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does OKYO Pharma's Market Cap compare to ENTX and HRTX?
According to the Biotechnology industry distribution chart, OKYO Pharma ranks #798 out of 1426 companies for Market Cap. This places OKYO Pharma in the lower half of its industry. The industry median Market Cap is 119.23. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 119.23, based on 1,426 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on OKYO Pharma and its competitors. For the Biotechnology industry, the median Market Cap is 119.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. OKYO Pharma's current Market Cap is €87.61 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OKYO Pharma stock overvalued right now?
OKYO Pharma (STU:OK10) has a current Market Cap of €87.61 Mil. The current Market Cap is €87.61 Mil. OKYO Pharma's overall GF Score™ is 23/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For OKYO Pharma (STU:OK10), the current Market Cap is €87.61 Mil as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.
23GF Score
Get the complete analysis for STU:OK10
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:OK10 has been successfully added to your 
